Overall, this study identified a novel regulatory axis, RAB4A–NUMB–NOTCH1–RAC1 in regulating cancer stemness and tumor initiation and progression and these targets may be further investigated for drug development and cancer therapeutics. Here, RAC1 is linked to cancer.